Cargando…

COVID-19 vaccines: A perspective from social pharmacology

Social pharmacology is a branch of clinical pharmacology, which depicts relationships between society and drugs and in particular factors, reasons, social consequences of drug use as well as representations of drugs in the society. Recent development and marketing of coronavirus disease 2019 (COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Montastruc, Jean-Louis, Lafaurie, Margaux, de Canecaude, Claire, Montastruc, François, Bagheri, Haleh, Durrieu, Geneviève, Sommet, Agnès
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161798/
https://www.ncbi.nlm.nih.gov/pubmed/34119317
http://dx.doi.org/10.1016/j.therap.2021.05.010
_version_ 1783700578513190912
author Montastruc, Jean-Louis
Lafaurie, Margaux
de Canecaude, Claire
Montastruc, François
Bagheri, Haleh
Durrieu, Geneviève
Sommet, Agnès
author_facet Montastruc, Jean-Louis
Lafaurie, Margaux
de Canecaude, Claire
Montastruc, François
Bagheri, Haleh
Durrieu, Geneviève
Sommet, Agnès
author_sort Montastruc, Jean-Louis
collection PubMed
description Social pharmacology is a branch of clinical pharmacology, which depicts relationships between society and drugs and in particular factors, reasons, social consequences of drug use as well as representations of drugs in the society. Recent development and marketing of coronavirus disease 2019 (COVID-19) vaccines raises a number of questions of social pharmacology: are vaccines drugs like any other? What is their perception at the individual, population and societal levels? How do individuals perceive the risks and benefits of these vaccines? What is the perception at the societal level? What is the individual and societal acceptability of these vaccines during a pandemic? All these questions are discussed in the light of recent data. A number of proposals, both at the individual and at the collective or population level, are formulated to help solve these problems of social pharmacology.
format Online
Article
Text
id pubmed-8161798
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-81617982021-05-28 COVID-19 vaccines: A perspective from social pharmacology Montastruc, Jean-Louis Lafaurie, Margaux de Canecaude, Claire Montastruc, François Bagheri, Haleh Durrieu, Geneviève Sommet, Agnès Therapie COVID-19/Social pharmacology Social pharmacology is a branch of clinical pharmacology, which depicts relationships between society and drugs and in particular factors, reasons, social consequences of drug use as well as representations of drugs in the society. Recent development and marketing of coronavirus disease 2019 (COVID-19) vaccines raises a number of questions of social pharmacology: are vaccines drugs like any other? What is their perception at the individual, population and societal levels? How do individuals perceive the risks and benefits of these vaccines? What is the perception at the societal level? What is the individual and societal acceptability of these vaccines during a pandemic? All these questions are discussed in the light of recent data. A number of proposals, both at the individual and at the collective or population level, are formulated to help solve these problems of social pharmacology. Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2021 2021-05-28 /pmc/articles/PMC8161798/ /pubmed/34119317 http://dx.doi.org/10.1016/j.therap.2021.05.010 Text en © 2021 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle COVID-19/Social pharmacology
Montastruc, Jean-Louis
Lafaurie, Margaux
de Canecaude, Claire
Montastruc, François
Bagheri, Haleh
Durrieu, Geneviève
Sommet, Agnès
COVID-19 vaccines: A perspective from social pharmacology
title COVID-19 vaccines: A perspective from social pharmacology
title_full COVID-19 vaccines: A perspective from social pharmacology
title_fullStr COVID-19 vaccines: A perspective from social pharmacology
title_full_unstemmed COVID-19 vaccines: A perspective from social pharmacology
title_short COVID-19 vaccines: A perspective from social pharmacology
title_sort covid-19 vaccines: a perspective from social pharmacology
topic COVID-19/Social pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161798/
https://www.ncbi.nlm.nih.gov/pubmed/34119317
http://dx.doi.org/10.1016/j.therap.2021.05.010
work_keys_str_mv AT montastrucjeanlouis covid19vaccinesaperspectivefromsocialpharmacology
AT lafauriemargaux covid19vaccinesaperspectivefromsocialpharmacology
AT decanecaudeclaire covid19vaccinesaperspectivefromsocialpharmacology
AT montastrucfrancois covid19vaccinesaperspectivefromsocialpharmacology
AT bagherihaleh covid19vaccinesaperspectivefromsocialpharmacology
AT durrieugenevieve covid19vaccinesaperspectivefromsocialpharmacology
AT sommetagnes covid19vaccinesaperspectivefromsocialpharmacology